Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
What are the four actions of the non selective COX inhibitors?
|
anit-inflammatory, Anti-platelet, Anti-pyretic, and analgesic
|
|
Acetaminophen exhibits which two properties?
|
anti-pyretic and analgesic
|
|
MOA of the non selective COX inhibitors
|
blocks cyclooxygenase COX pathway, limiting prostaglandin synthesis
|
|
Difference between aspirin and other non selective COX inhibitors
|
aspirin is irreversable
|
|
Name the three oral, reversible non selective COX inhibitors
|
Ibuprofin, Indomethacin, and naproxen
|
|
Which NSAID is available in a parenternal formulation and is mainly used for its analgesic properties.
|
Ketorlac
|
|
Ketorlac use is restricted to 72 hours due to which side effects?
|
GI and renal damage
|
|
Which non selective, oral, COX inhibitor has the highest anti-inflammatory property, and is a 1st line treatment of a gouty attack?
|
Indomethacin (reduces prostaglandin, and crystal phagocytosis by macrophages)
|
|
Toxicity of Aspirin
|
tinnitis, vertigo, GI bleeding, and increased bleeding time, risk of reyes syndrome in kids with viruses.
|
|
Common side effects of all NSAIDS
|
risk of renal damage, especially in preexisting renal disease, and GI upset.
|
|
What is acetaminophen, what is it used for?
|
is an OTC antipyretic/analgesic, used in patients with renal disease. metabolized by liver
|
|
Toxicity of acetaminophen
|
hepatic failure in cases of overdose due to toxic metabolite by phase II reactions. Alcohol predisposes to this toxicity
|
|
Antidote for Acetaminophen poisoning
|
N-acetylcysteine. used to regenerate glutathione, and continue degredation of toxic metabolite
|
|
What are the COX 2 inhibitors, and why were they developed?
|
Celecoxib, refecoxib, valdecoxib. developed to limit GI effects of non selective NSAIDs
|
|
Toxicities of COX 2 selective inhibitors
|
renal toxicity, as well as increased risk of myocardial infarction and stroke. this is due to the increased inhibition of prostacyclin (PGI2), than over TXA2. causes platelet aggregation and vasoconstriction
|
|
What are DMARDS, and what is their clinical use?
|
slow active disease modifying drugs, may take 6 weeks to 6 months to have effect. Limit or even reverse progression of Rheumatic disease
|
|
What class of drugs have an intermediate effect on rheumatic disease, but are too toxic for long term, chronic use?
|
corticosteroids, reduce inflammation, and other immune responses in rheumatic disease.
|
|
Which cytotoxic drug acts by limiting the number of immune cells available to carry out inflammatory response?
|
methotrexate, also used to treat cancer, inhibits dihydrofolate reductase (thereby stopping DNA synthesis)
|
|
Toxicity of methotrexate
|
nausea, mucosal ulcers, hematotoxicity, hepatotoxicity, teratogenicity
|
|
Antidote used for methotrexate overdose
|
Leucovorin
|
|
DMARD drugs used that interfere with activity of T lymphocytes
|
sulfasalazine, cyclosporin, hydroxychloroquine.
|
|
Toxicity of T lymphocyte altering DMARDS
|
hepatotoxicity, GI disturbance, rash, headache, leukopenia
|
|
DMARD drugs that act by limiting activity of B lymphocytes and macrophages
|
Rituximab for B lymphocytes Gold compounds for macrophages
|
|
Other use for Rituximab and toxicities
|
also used for Non-Hodgkins lymphoma, causes infusion reaction, rash, infection, and cardiac toxicity
|
|
Other use for Hydroxychloroquine
|
anti malarial
|
|
Other use for Sulfasalazine
|
Ulcerative colitis
|
|
Other use for methotrexate
|
cancer treatment
|
|
Other use for cyclosporine
|
tissue transplant
|
|
What immunoglobulin based biologic agents work by inhibiting Tumor necrosis factor A, and have shown success in treating RA?
|
Infliximimab, adalimumab, and entarecept.
|
|
What is another major use for the tumor necrosis factor A drugs?
|
Crohn's disease
|
|
Which DMARD for RA works as an interleukin 1 receptor antagonist
|
Anakinra, causes infection, worsening of COPD, and hypersensitivity reactions
|
|
DMARDS have also shown to be of use in what other autoimmune diseases?
|
SLE, sjogrens arthritis, JRA, and ankylosing Spondylitis,
|
|
What are the 3 treatment strategies associated with gout?
|
1) reduce inflammation during acute attacks 2) accelerating renal excretion of uric acid 3) reducing conversion of purines to uric acid
|
|
Which treatment of acute gout works by inhibiting microtubule assembly, reducing leukocyte migration, and phagocytosis? also works with familial mediterranean fever
|
colchicine. is a general mitotic poison, and is being phased out due to severe liver and kidney damage
|
|
What is the standard 1st line treatment for acute gouty attacks, and is used in conjunction with other treatments to reduce risk of acute attack?
|
indomethacin. (NSAID) anti-inflammatory. reduces protsaglandin formation, and phagocytosis of crystals by macrophages
|
|
What are the uricosuric agents, and how do they work
|
probenecid and sulfinpyrazone. these are weak acids that compete for reabsorption in in the proximal tubules. at low doses can compete for secretion (bad)
|
|
When should these be used, and why should they be combined initially with indomethacin?
|
they can precipitate an acute attack during early use, should not be used for treatment of initial attack. Indomethacin reduces chance of precipitating an attack
|
|
What are the Xanthine Oxidase inhibitors? what are they used for?
|
Allipurinol and febuxostat. these are used to reduce formation of uric acid in the body, by inhibit xanthane oxidase, which breaks down hypoxanthine and xanthine into uric acid. Allopurinol is a suicide inhibitor, and febuxostat is a non purine inhibitor, and is more selective
|
|
When should these be used, and why are they combined with indomethacin?
|
not for 1-2 weeks after acute attack. combined with indomethacin because they can induce an acute attack
|
|
What other clinical use is there for Allopurinol?
|
used as adjunct to cancer therapy to slow the formation of uric acid from purines released by the death of large numbers of neoplastic cells
|
|
Toxicities of allopurinol
|
GI upset, rash, peripheral neuritis, vasculitis, aplastic anemia. Also inhibits metabolism of mercaptopurine and azathioprine, drugs which need xanthine oxidase for metabolization
|
|
Toxicities of Febuxostat
|
liver function abnormalities, headaches, and GI upset
|